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Undifferentiated or anaplastic thyroid carcinoma (ATC) is rare and one of the most aggressive human malignancies. 
The tumor is usually voluminous and fast-growing and mostly affects older women. The most common sites of distant 
metastases are the lungs, brain, and bones. Herein, we describe the case of a 66-year-old woman with a history of bilateral 
breast carcinoma and ATC, who presented with an acute abdomen and subsequently died. At autopsy, an isolated 
metastasis of ATC in the small intestine leading to bowel perforation was found. Moreover, there was adenocarcinoma 
in the descending colon. The review of extra-abdominal malignancies metastasizing to bowel and coincidence of breast 
and thyroid carcinoma is included. 
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INTRODUCTION
Undifferentiated or anaplastic thyroid carcinoma 
(ATC) is rare and is one of the most aggressive human 
malignancies. The ATC is composed of undifferentiated 
thyroid follicular cells. It occurs typically in older 
females. The majority of patients succumb to the 
metastatic disease within 6 months. The most 
common sites of metastases are the lungs, brain, and 
bones.1 Herein, we describe an unusual case of ATC 
metastasizing to the small bowel without evidence of 
any other distant metastasis, resulting in the bowel 
perforation and peritonitis, which subsequently caused 
the patient’s death.
CASE REPORT
A 66-year-old Caucasian woman presented to 
the Surgery Department with acute abdominal signs, 
following a 2-day history of fever and abdominal pain. 
At the presentation, the patient was febrile (38.1°C), 
with notable abdominal distension, without nausea. 
There were palpation signs of peritonism, with bilateral 
hypogastric pain. Intestinal sounds were present. Her 
medical history included type-2 diabetes, bilateral breast 
cancer, and ATC. The breast cancers were both pT1N0 
invasive ductal breast carcinoma, operated on 2 and 
5 years ago. After the first mastectomy, the patient 
was also submitted to radiotherapy, and after the 
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second surgery, she was kept on tamoxifen. An ATC 
was diagnosed 2 months ago. She was submitted to a 
palliative right side hemithyroidectomy and right block 
neck dissection of groups II–V because of a voluminous 
bilateral tumor of the thyroid involving the carotid artery, 
and four out of six resected lymph nodes (Figure 1).
The laboratory workup revealed a marked 
elevation of C-reactive protein (167.8 mg/L; reference 
range [RR] <5) and leukocytosis 21.9 × 109/ l 
(RR 4.0-10.0). The abdominal computer tomography 
revealed pneumoperitoneum. An exploratory 
laparotomy was scheduled, but while waiting for this, 
the patient developed shortness of breath, a cough, 
inspiratory crackles, and room-air pulse oximetry of 
70%. The patient did not report any chest pain. Due 
to the resulting loss of consciousness, she underwent 
orotracheal intubation but thereafter experienced 
a cardiac arrest. Cardiopulmonary resuscitation 
maneuvers were performed; however, the patient did 
not survive. Aiming to clarify the cause of death, an 
autopsy was performed.
AUTOPSY FINDINGS
The external examination revealed a scar in the 
patient’s neck region, older scars related to the bilateral 
mastectomy, and a bloated abdomen. The abdominal 
cavity opening revealed a markedly distended intestine, 
and the visceral peritoneum was covered with pus. 
There was a perforation of the small intestine measuring 
4 mm at 2 meters from the ileocecal junction. An 
indurated ulceration with an elevated firm margin 
measuring 30 × 20 mm underlying the perforation 
was found in the intestinal mucosa (Figure 2A). Also, 
there was a cauliflower-shaped polypoid tumor in the 
mucosa of the descending colon.
The right thyroid lobe was absent, and the 
remaining left lobe was markedly enlarged and firm. 
Almost the entire bulk of the gland tissue was replaced 
by a whitish and partly necrotic tumor mass measuring 
70 × 30 × 10 mm (Figure 2B), which infiltrated the 
surrounding tissue and lymph nodes.
The lungs were heavy and boggy. The right lung 
weighed 940 g (mean RR: 450 g), and the left lung 
weighed 860 g (mean RR: 375 g). A significant amount 
of foamy fluid drained out from the cut section of the 
lungs, consistent with lung edema. No metastatic foci 
were found in the lung parenchyma. The heart weighed 
460 g (mean RR: 280 g) and showed left ventricular 
hypertrophy. Advanced calcifying atherosclerosis was 
found in the aorta and major arteries.
A pendulating polyp in the uterine cavity was 
incidentally found. Besides the tumors in the thyroid 
and adjacent lymph nodes, and in the small intestine 
and colon, there were no other sites of metastases.
The histology of the thyroid gland tumor 
consisted of pleomorphic epithelioid cells with marked 
cytonuclear atypia, rich mitotic activity, and admixed 
chronic inflammatory cells and necrosis (Figure 3A). This 
finding was similar to the hemithyroidectomy specimen 
histological report of the previous 2 months; that is, 
undifferentiated (anaplastic) thyroid carcinoma. In the 
vicinity of the thyroid gland, two lymph nodes with 
metastases were found. Immunohistochemically, the 
tumor was positive for cytokeratin AE1/3 (Figure 3B), 
whereas the remaining examined markers, paired 
box 8 (PAX8), thyroid transcription factor-1 (TTF-1), 
chromogranin A, carcinoembryonic antigen (CEA), and 
epithelial membrane antigen (EMA), were negative. 
Non-neoplastic thyroid follicular cells showed strong 
nuclear TTF-1-positivity. Expression of p53 was wild 
type in the tumor. The proliferation activity (Ki67) was 
present in approximately 80% of tumor cell nuclei.
A similar malignant epithelioid tumor was found 
in the small intestine wall at the perforated ulceration 
Figure 1. Cervical computed tomography scan 
showing voluminous tumor of the thyroid gland with a 
preponderating mass in the right lobe embedding the 
right carotid artery.
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Figure 2. A – Gross view of a small bowel segment showing a perforated ulceration measuring approx. 30 × 
20 mm. B – Gross picture of the left lobe of the thyroid gland containing a white, firm, tumorous mass with the 
adjacent lymph node infiltrated by the tumor.
site (Figure 4). We considered this lesion as a perforated 
metastasis of ATC in the small intestine. The tumor 
cells were cytokeratin 20- and CDX2-negative. The 
p53 expression was wild type. Fibrin precipitations 
and abundant neutrophils were present on the visceral 
peritoneum, consistent with the diagnosis of purulent 
peritonitis.
A wel l-differentiated, invasive, intest inal 
adenocarcinoma with submucosal invasion originating 
in a tubular adenoma was found in the descending 
colon without metastases on a thorough gross 
examination (Figure 5).
There was a corporal endometrial polyp in the 
uterine cavity. The histology of the left ventricular 
myocardium displayed hypertrophy and small dispersed 
scars. Alveolar edema was found in both lungs, without 
hyaline membranes.
The autopsy findings rendered the diagnosis 
of an ATC as the underlying disease, complicated 
by an isolated perforated metastasis in the small 
intestine. Purulent peritonitis and sepsis were the 
immediate cause of death. With the patient’s history 
of metachronous bilateral breast cancer, and an 
incidental finding of colonic adenocarcinoma, the 
patient suffered from tumor quadruplicity.
DISCUSSION
ATC is a highly aggressive tumor composed of 
undifferentiated cells, which may arise de novo or in 
a differentiated thyroid malignancy; that is, papillary 
carcinoma. ATC arising in a papillary thyroid carcinoma 
has been described in relation to the expression of 
cancer stem cell markers. These have been documented 
in ATCs as a hallmark of adverse outcome.2
Grossly, the ATCs are usually voluminous and 
infiltrative and are light and fleshy on the cut section—
often with necrosis and hemorrhage. Microscopically, 
the tumor cells are often pleomorphic with significant 
cytonuclear atypia. A sarcomatoid, giant cell or 
epithelioid pattern may be observed. Vascular invasion 
is a frequent feature.1
Histopathological diagnosis may be challenging. 
PAX8 is a transcription factor expressed in normal and 
neoplastic thyroid follicular epithelium widely used by 
pathologists as an immunohistochemical marker of 
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thyroid origin in neoplasms. However, the sensitivity 
is notably lower in ATC than that believed in previous 
studies,3 whereas a recent study by Lai et al.4 proved 
a PAX8-positivity in only 54% of ATCs. Even the 
cytokeratins and EMA documenting their epithelial 
nature are expressed in only 55%–65% of ATCs.5,6 
A mutation of tumor suppressor gene TP53 occurs 
in most ATCs7,8 and may be proven by strong diffuse 
positivity or full negativity of p53 immunohistochemistry. 
However, this is unspecific; in our case, there was a p53 
wild type expression. In regard to differential diagnosis, 
poorly differentiated thyroid carcinoma as an unusual 
variant of papillary carcinoma may be considered due to 
abundant mitotic figures and necrosis9 observed in our 
case. Moreover, there is an exceedingly rare spindle cell 
variant of papillary carcinoma distinct from ATC described 
in the literature.10 Nevertheless, bizarre high-grade 
nuclear atypia, PAX8- and TTF-1-negativity support rather 
Figure 3. Photomicrograph of the thyroid tumor. A – A malignant tumor consisting of highly pleomorphic epithelioid 
cells with marked cytonuclear atypia, including bizarre cells and mitotic figures (H&E, 44.8X). B – Cytokeratin 
positivity in the tumor cells (left) and the non-neoplastic thyroid follicles (right) (AE1/3 15,8x).
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our diagnosis of ATC. Spindle-shaped cells may occur in 
medullary thyroid carcinoma, which may be dominated 
or exclusively composed of spindle cells.9 However, we 
prefer ATC diagnosis because of chromogranin-negativity 
and marked cytonuclear pleomorphism. Sarcomas of 
the thyroid gland, both primary and metastatic, are 
extraordinarily rare, and we may exclude these by the 
strong cytokeratin positivity in our case.
There are ATC cases that lack a reliable diagnostic 
marker. Distinguishing the primary thyroid tumor from 
metastasis often remains a diagnosis of exclusion, 
which was evidenced by the autopsy in our case.
The ATC annual incidence counts for one to two 
cases per million persons.11 The prognosis is extremely 
poor, with a median 1-year survival rate of only 
10%–20%.12-14 The tumor occurs in older persons and 
is slightly more frequent in women. The patients often 
Figure 4. Photomicrograph of the intestinal perforation site showing a pleomorphic tumor with similar morphology 
to the thyroid carcinoma infiltrating the small bowel submucosa (A), marked cytonuclear atypia, and mitotic activity 
in detail (B). (H&E, A 11.7X, B 57,0X.).
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present with metastatic involvement of regional lymph 
nodes at the diagnosis. Of the patients, 30%–40% 
have distant metastases—most often involving the 
lung, bone, and brain.1 Metastatic involvement of the 
intestine is unusual.
Generally, symptomatic metastases of extra-
abdominal malignancies in the intestines are rare. 
Regarding small bowel metastasis of thyroid carcinoma, 
we found five references in the medical literature15-19 
—all are related to ATC, three of them presented 
with intestinal perforation,17-19 as in our case. The 
most common primary tumors metastasizing to the 
small bowel are lung carcinomas20-42 and malignant 
melanoma,43-48 followed by renal cell carcinoma.49,50 Rare 
cases of testicular seminoma,51 osteosarcoma,52,53 and 
Ewing sarcoma54 have also been described. Symptoms 
of intestinal metastasis described in the literature include 
intussusception,16, 20-29, 43-54 and perforation17-19, 30-42.
Figure 5. Photomicrograph of the intestinal adenocarcinoma of the descending colon, with submucosal invasion, 
originating in a tubular adenoma. (H&E, A 2.1X, B 21,3X.).
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The curative treatment of ATC is multimodal 
and consists of surgery and external beam radiation 
therapy with radio-sensitizing chemotherapy.11 The 
combined therapy tends to have a better outcome 
than a single modality alone.55 In terms of targeted 
therapy, there are some successful trials with selective 
BRAF-inhibitors, whereas BRAF mutation is seen in 
25% of tumors.11,56-58
There is an unsolved question of multiple 
malignancies (bilateral breast carcinoma, colonic 
carcinoma, thyroid carcinoma) in our patient. 
Notwithstanding a possibility of hereditary syndromes, 
there is evidence suggesting that breast cancer and 
thyroid cancer occur together in the same female 
patients more frequently than would be expected 
by chance, synchronously or metachronously.59,60 
There are several explanations being subject of recent 
research, focusing i.e., on detection bias, treatment 
effect, iodine intake, folate metabolism, obesity, 
gonadal hormones, thyroid hormone, and genetic 
susceptibility.61,62 Based on endocrinological studies, 
iodine deficiency may stimulate the gonadotropin 
secretion and then result in a hyperestrogenic state, 
which increases the risk of breast carcinoma.63 
Because thyroid carcinoma is highly prevalent among 
fertile women, hormonal and reproductive factors 
may also be involved in its incidence.64 Since these 
references mostly describe papillary thyroid carcinoma, 
we cannot exclude this as a lesion preexistent to 
ATC in our patient. Moreover, thyroid and breast 
carcinoma may be induced by radioactive iodine 
administration or by external beam radiation to the 
breast, respectively. Traditional risk factors, obesity, 
and radiation exposure increase the risk of both 
thyroid and breast cancer.62,65,66 In regard to genetic 
susceptibility, Goldgar et al.67 observed excess thyroid 
cancer rates among first-degree relatives of probands 
with breast cancer and vice versa. Cowden syndrome 
is an example of a hereditary tumor syndrome known 
to increase the risk of developing both breast and 
differentiated thyroid cancer in the same individual68 as 
no skin or gastrointestinal hamartomas were indicating 
Cowden syndrome in our case.
In conclusion, we report the unique case of a 
female patient suffering from tumor quadruplicity, 
while an ATC was the lethal tumor metastasizing to the 
small intestine leading to intestinal perforation, purulent 
peritonitis, and the patient’s death. Due to the autopsy 
nature of our material, the question of a hereditary 
tumor syndrome remains unresolved. We hypothesize 
that the presence of the ATC was induced by breast 
cancer radiotherapy many years ago. The patient’s 
general practitioner was informed of the autopsy results 
and all the facts noted above, with a recommendation 
to conduct a genetic examination of the patient’s family.
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